Source:
APRENTON, N.J. (AP) -- Sales of Johnson & Johnson pain relievers are collapsing as a string of recalls appears to have made consumers wary of once-sterling brands such as Tylenol and Benadryl.
An eighth recall, announced Thursday, could worsen consumer reaction. That wariness and the huge amount of products pulled off store shelves together look to be costing J&J tens of millions of dollars a month.
Thursday's recall by Johnson & Johnson's McNeil consumer health care unit covers 21 lots of products, including Children's Tylenol. Those were recalled because of a musty or moldy smell, extending a large Jan. 15 recall tied to a nauseating chemical on shipping pallets.
The company said the new lots were added to the recall as a precaution after an internal review found those lots, shipped and stored before Jan. 15, had been on the same type of wooden pallets.
Read more:
http://finance.yahoo.com/news/JJ-sales-plunge-as-new-drug-apf-1957993514.html?x=0
Another article said:
All lots involved in the recall were produced before the January 15, 2010 recall, after which McNeil stopped accepting shipments of materials from its suppliers on that type of pallet. They might have stopped accepting shipments of that type of pallet, but guess it would hurt profits too much to throw out all the pallets it previously had on hand.
The FDA's statement on this: "We do not see any serious health risk to the public from this additional recall"
Don't worry, no J&J execs were fired or harmed in any way in the process.